2024 annual financial data
TransCode Therapeutics 2024 Operating margin
TransCode Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -15,660,697 USD and net income was -16,754,971 USD.
Operating cash flow was -13,335,947 USD.
Get free TransCode Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -15,660,697 USD
- Net income
- -16,754,971 USD
- Operating cash flow
- -13,335,947 USD